Traitements2programmes
Essais1liés
Publications0liées
SourceDBlocale

Traitements

2
MoléculeIndication / populationPhaseObjectifPaysRésultat
Erythropoietin human recombinant (EPOrh)The purpose of this study is to determine whether recombinant human Erythropoietin (EPOrh) is safe in the treatment of patients with Parkinson's Disease. Parkinson Phase 1 À vérifier Cuba À vérifier
Erythropoietin human recombinant (EPOrh)The purpose of this study is to determine whether recombinant human Erythropoietin (EPOrh) is safe in the treatment of patients with Parkinson's Disease. Parkinson Phase 1 À vérifier Cuba À vérifier

Essais cliniques

1
MoléculeIndication / populationPhaseNCTTitreStatut
Erythropoietin human recombinant (EPOrh) Parkinson Phase 1 NCT01010802 Safety Study of Erythropoietin (EPO) in Parkinson's Disease COMPLETED

Publications

0
MoléculeIndication / populationTitreJournalDate
Aucune publication.